Congress Wants Answers From US FDA On India And China Inspection Plans

 
• By Michael McCaughan

House Republicans keep the pressure on the US FDA for plans to catch up on inspections after the long COVID-19 hiatus. Recent cancer drug shortages could be a headline event to lead into a larger probe.

drug manufacturing
The House Energy and Commerce Committee wants more information about FDA inspection efforts in India and China. • Source: Shutterstock

More from Manufacturing

More from Compliance